Determinants of R&D Disclosures of Nasdaq-Listed Biotechnology Firms
This study investigates the determinants of discretionary research and development (R&D) disclosures of biotechnology firms listed on the NASDAQ. Our study proposes that firms with higher levels of information asymmetry are more likely to disclose information about R&D than f...
Saved in:
Main Authors: | TAN, Pearl Hock Neo, GAN, Peck-Yen, LOW, Calvin, Chim, Wai-Kay |
---|---|
格式: | text |
語言: | English |
出版: |
Institutional Knowledge at Singapore Management University
2005
|
主題: | |
在線閱讀: | https://ink.library.smu.edu.sg/soa_research/76 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
An empirical study of voluntary research and development disclosures of biotechnology firms listed on NASDAQ
由: Gan, Peck Yen, et al.
出版: (2008) -
The Information Content of Trades of Inactive Nasdaq Stocks
由: CHEN, Peter, et al.
出版: (2003) -
Speculative bubbles in the recent AI boom: Nasdaq and the Magnificent Seven
由: BASELE, Rerotlhe B., et al.
出版: (2025) -
Voluntary disclosure in the biotechnology industry
由: Pan, Grace Meiyun, et al.
出版: (2008) -
Determinants of Internet Reporting by Chinese Listed Companies
由: TAN, Pearl Hock Neo, et al.
出版: (2004)